5 Best Stocks to Buy Now According to Jeffrey Diehl's Adams Street Partners
In this article, we discuss the 5 best stocks to buy now according to Jeffrey Diehl's Adams Street Partners.
Icosavax Inc. (ICVX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vivo Capital Albert Cha And Frank Kung | 0 | $0 | 0% | |
| 2. | Syquant Capital Olivier Leymarie And Henri Jeantet | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.10 | 42,225 | Director | 50,243 | 2022-04-01 | Filing | |
| $4.75 | 8,900 | Large Shareholder, Director | 5,963,565 | 2022-03-29 | Filing | |
| $4.53 | 175,318 | Large Shareholder, Director | 5,953,665 | 2022-03-28 | Filing | |
| $15.00 | 133,334 | Other | 2,883,329 | 2021-08-02 | Filing | |
| $15.00 | 171,766 | Large Shareholder, Director | 638,668 | 2021-08-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.29 | 15,000 | 358,657 | 2024-02-01 | Filing | ||
| $15.70 | 106,373 | Officer | 223,980 | 2023-01-04 | Filing | |
| $15.67 | 15,000 | Officer, Director | 260,641 | 2024-01-02 | Filing | |
| $15.43 | 40,000 | Officer, Director | 260,641 | 2023-12-21 | Filing | |
| $15.44 | 50,000 | Officer, Director | 300,641 | 2023-12-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,703,704 | $58,370,375 | 6.47% | |
| 2. | 3,510,228 | $55,321,193 | 50.65% | |
| 3. | 2,581,530 | $40,684,912 | 0% | |
| 4. | 2,240,524 | $35,310,658 | 0% | |
| 5. | 1,830,058 | $28,841,714 | 0% |
News See All
Top 10 Stock Picks of Jeffrey Diehl's Adams Street Partners
In this article, we will be taking a look at the top 10 stock picks of Jeffrey Diehl's Adams Street Partners.
5 Biotech Stocks to Buy Today According to Kerr Neilson's Platinum Asset Management
In this piece, we will take a look at the five biotechnology stocks to buy today according to Kerr Neilson's Platinum Asset Management.
15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky's RA Capital
In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky's RA Capital.
Billionaire Hedge Funds
